Dr. Danielle Antin Ozerkis

Biography

Danielle Antin-Ozerkis, MD, specializes in the evaluation and management of advanced lung disease and is the Medical Director of the Yale Medicine Interstitial Lung Disease Program. She has a profound focus on diagnostic treatment options for interstitial lung diseases, particularly idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung disease. She leads a multidisciplinary team that meets weekly to discuss patient cases and research, ensuring a patient-centric approach. Dr. Antin-Ozerkis’s work includes conducting clinical drug trials focusing on various forms of pulmonary fibrosis, and she has served as a primary investigator in these studies. Additionally, she is involved in a translational research program aimed at understanding the mechanisms behind the development and progression of pulmonary fibrosis. A graduate of Princeton University, she completed her MD at the University of Pennsylvania and has held a variety of academic positions during her career, including a prominent role in pulmonary medicine at Yale.

Research Interests

Experience